News

Healthcare, Life Sciences

All news
Semble lève 35 millions d'euros et accélère son déploiement en France
08/07/2026
Funding & Fundraising

Semble raises 35 million euros to accelerate its rollout in France

Semble, a UK-based clinical software platform, has announced a 35 million euro round led by Revaia and Partech. With more than 10 million patients already supported across Europe, the company will use the fresh capital to establish itself as the leading connected health infrastructure in the French market, one of the most demanding and heavily […]
Bionyra Pharma lève 143 millions d'euros pour ses biothérapies contre les maladies inflammatoires sévères
07/07/2026
Mergers & Acquisitions

Bionyra Pharma raises 143 million euros for its biotherapies against severe inflammatory diseases

Bionyra Pharma, a Paris-based biotech founded in 2025, formally announced on 22 June 2026 a 143 million euro fundraising, described as the largest ever completed by a French biotech. The proceeds will finance the clinical development of three molecules for the treatment of severe atopic dermatitis and chronic inflammatory bowel diseases. Analysis by the experts […]
Healthcare Holding Schweiz acquiert Compet Medical un nouveau jalon dans la consolidation des technologies médicales en Suisse
30/06/2026
Mergers & Acquisitions

Healthcare Holding Schweiz acquires Compet Medical: a new milestone in the consolidation of medical technologies in Switzerland

Healthcare Holding Schweiz is methodically pursuing its consolidation strategy in Switzerland’s medical technology and healthcare products sector. The acquisition of Compet Medical, a supplier of harm reduction products for more than 30 years, illustrates the approach of a platform building its portfolio step by step, focusing on niches with strong societal and institutional value. Analysis […]
MedTech française : un secteur en effervescence porté par l'IA et la structuration des données
08/06/2026
Financial News

French MedTech: a thriving sector driven by AI and structured data

The healthcare sector is undergoing a deep transformation. Valuations have normalised, capital is flowing to the most differentiated assets, and artificial intelligence is no longer a selling point: it has become the first thing acquirers screen for. For the leaders of French MedTechs, this environment is rewriting the rules of M&A. A quieter market that […]
UroMems lève 60 millions de dollars : une medtech grenobloise entre dans la dernière ligne droite avant la commercialisation
05/06/2026
Funding & Fundraising

UroMems raises 60 million dollars: a Grenoble-based medtech enters the home stretch before commercialisation

Fifteen years of research, three financing rounds, and an implant unlike any other in the world. In May 2026, UroMems is reaching the most decisive milestone in its history: a 60 million dollar fundraising entirely backed by a leading US investor, which places the Grenoble-based medtech within reach of regulatory approval in the United States […]
Sêmeia lève 21 millions d'euros : la télésurveillance médicale entre dans sa phase de consolidation
26/05/2026
Funding & Fundraising

Sêmeia raises 21 million euros: remote medical monitoring enters its consolidation phase

With a profitable model, two acquisitions already completed and a platform deployed across more than 500 healthcare facilities, Sêmeia is not a startup in search of validation. It is a player that has proven its model and is now raising funds to accelerate its growth. This 21 million euro fundraising illustrates the growing maturity of […]
See More